The Effect of Anandamide on Uterine Nitric Oxide Synthase Activity Depends on the Presence of the Blastocyst
Author Information
Author(s): Sordelli Micaela S., Beltrame Jimena S., Burdet Juliana, Zotta Elsa, Pardo Romina, Cella Maximiliano, Franchi Ana M., Ribeiro Maria Laura
Primary Institution: Laboratorio de Fisiología y Farmacología de la Reproducción, CEFYBO (CONICET – UBA), Buenos Aires, Argentina
Hypothesis
Low anandamide levels near implantation sites might increase nitric oxide synthase (NOS) activity, while high levels at inter-implantation sites might decrease it.
Conclusion
Anandamide levels at implantation sites modulate nitric oxide synthase activity, which is crucial for embryo implantation.
Supporting Evidence
- NOS activity was higher in the receptive pre-implantation uterus and at the sites of embryo implantation compared to inter-implantation sites.
- Anandamide inhibited NOS activity through CB2 receptors in the absence of a blastocyst.
- Once implantation begins, anandamide inhibited NOS via CB1 receptors at implantation sites.
Takeaway
This study found that a substance called anandamide affects how a rat's uterus produces a chemical important for pregnancy, and this effect depends on whether an embryo is present.
Methodology
The study used in vitro experiments with rat uterine tissues to measure nitric oxide synthase activity in response to anandamide and its interaction with cannabinoid receptors.
Limitations
The study was conducted in rat models, which may not fully replicate human physiology.
Participant Demographics
Female Wistar rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website